| 臺大學術典藏 |
2021-05-31T07:03:35Z |
Inhibition of RPE cell-mediated matrix adhesion and collagen gel contraction by crovidisin, a collagen-binding snake venom protein
|
Yang C.-H.; Liu C.-Z.; TUR-FU HUANG; Yang C.-M.; Liu K.-R.; Chen M.-S.; Hung P.-T. |
| 臺大學術典藏 |
2021-05-26T09:08:36Z |
Autologous bone marrow transplantation for plasma cell leukemia: Report of a case
|
Yang C.-H.; Lin M.-T.; Tsay W.; Liu L.T.; Wang C.-H.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:35Z |
Lymphoblast colony-culture assay in acute lymphoblastic leukemia: A quantitative approach
|
Hong R.-L.; Shen S.-W.; Lin M.-T.; Tien H.-F.; Yang C.-H.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:32Z |
Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome
|
Yeh K.H.; Hsieh H.C.; Tang J.L.; Lin M.T.; Yang C.H.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:26Z |
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer
|
Hsu C.; Yeh K.-H.; Hong R.-L.; Yang C.-H.; Lin M.-T.; YAO-CHANG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:22Z |
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
|
Yang C.-H.; Kuo M.-L.; Chen J.-C.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:21Z |
Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: An useful salvage therapy
|
Huang S.-Y.; Yang C.-H.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:20Z |
BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells
|
Yang C.-H.; Schneider E.; Kuo M.-L.; Volk E.L.; Rocchi E.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:18Z |
Novobiocin sensitizes BCRP/MXR/ABCP overexpressing topotecan-resistant human breast carcinoma cells to topotecan and mitoxantrone
|
Yang C.-H.; YAO-CHANG CHEN; Kuo M.-L. |
| 臺大學術典藏 |
2021-05-26T03:35:12Z |
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
|
Yang C.H.; Tsai C.M.; Wang L.S.; Lee Y.C.; Chang C.J.; Lui L.T.; Yen S.H.; Hsu C.; Cheng A.L.; Liu M.Y.; Chiang S.C.; Chen Y.M.; KWEN-TAY LUH; Huang M.H.; Yang P.-C.; Perng R.-P. |
| 臺大學術典藏 |
2021-05-18T08:25:11Z |
Differential alteration in reproductive toxicity of medaka fish on exposure to nanoscale zerovalent iron and its oxidation products
|
Yang, C.-H.;Kung, T.-A.;Chen, P.-J.; Yang, C.-H.; Kung, T.-A.; Chen, P.-J.; PEI-JEN CHEN |
| 臺大學術典藏 |
2021-05-06T08:26:08Z |
Latent tuberculosis infection treatment for prison inmates: A randomised controlled trial
|
Chan P.-C.; Yang C.-H.; Chang L.-Y.; Wang K.-F.; Lu B.-Y.; Lu C.-Y.; PEI-LAN SHAO; Hsueh P.-R.; Fang C.-T.; Huang L.-M. |
| 臺大學術典藏 |
2021-05-03T02:21:08Z |
Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions
|
Shao Y.-Y.; Hu F.-C.; JIN-TUNG LIANG; Chiu W.-T.; Cheng A.-L.; Yang C.-H. |
| 臺大學術典藏 |
2021-04-29T05:09:19Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; KUAN-YU CHEN; Su W.-P.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:17Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:15Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y.; Shih J.-Y.; Yang C.-H.; KUAN-YU CHEN; Ho C.-C.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:15Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; KUAN-YU CHEN; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:14Z |
Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer
|
Lee J.-H.; Yu C.-J.; KUAN-YU CHEN; Shih J.-Y.; Lin Y.-L.; Yang C.-H. |
| 臺大學術典藏 |
2021-04-29T05:09:14Z |
Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors
|
KUAN-YU CHEN; Chen J.-H.; Shih J.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:12Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Shih J.-Y.; KUAN-YU CHEN; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:11Z |
Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed
|
Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; KUAN-YU CHEN; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:10Z |
Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors
|
Hsu C.-L.; KUAN-YU CHEN; Shih J.-Y.; Ho C.-C.; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-26T05:38:18Z |
Cellular studies via dielectrophoresisbased cellular microarray chip
|
Hsiung L.C.; Chiu C.L.; Yang C.H.; Wo A.M.; Lee H.; Jong D.S.; Chiu C.H.; Cheng J.Y.; MING-CHIH HO; Hsu C.Y.; Hsu M.C. |
| 臺大學術典藏 |
2021-04-23T05:56:27Z |
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
|
Wu Y.-L.;Cheng Y.;Zhou J.;Lu S.;Zhang Y.;Zhao J.;Kim D.-W.;Soo R.A.;Kim S.-W.;Pan H.;Chen Y.-M.;Chian C.-F.;Liu X.;Tan D.S.W.;Bruns R.;Straub J.;Johne A.;Scheele J.;Park K.;Chih-Hsin Yang;Liu Z.;Chen X.;Wang M.;Yu S.;Zhang H.;Fang J.;Li W.;Yang C.-H.;Chang G.-C.;Hsia T.-C.;Yang C.-T.;Wang C.-C.;Cho B.C.;Lee K.H.;Kim Y.-C.;An H.J.;Woo I.S.;Cho J.Y.;Shin S.W.;Lee J.-S.;Kim J.-H.;Yoo S.S.;Kato T.;Shinagawa N.;Tan S.W.D.;Ngo L.S.-M.;Ratnavelu K.;Ahmad A.R.;Liam C.K.;De Marinis F.;Tassone P.;Molla A.I.;Calles Blanco A.;Lazaro Quintela M.E.;Felip Font E.;Dingemans A.-M.;Bui L.; Wu Y.-L.; Cheng Y.; Zhou J.; Lu S.; Zhang Y.; Zhao J.; Kim D.-W.; Soo R.A.; Kim S.-W.; Pan H.; Chen Y.-M.; Chian C.-F.; Liu X.; Tan D.S.W.; Bruns R.; Straub J.; Johne A.; Scheele J.; Park K.; CHIH-HSIN YANG; Liu Z.; Chen X.; Wang M.; Yu S.; Zhang H.; Fang J.; Li W.; Yang C.-H.; Chang G.-C.; Hsia T.-C.; Yang C.-T.; Wang C.-C.; Cho B.C.; Lee K.H.; Kim Y.-C.; An H.J.; Woo I.S.; Cho J.Y.; Shin S.W.; Lee J.-S.; Kim J.-H.; Yoo S.S.; Kato T.; Shinagawa N.; Tan S.W.D.; Ngo L.S.-M.; Ratnavelu K.; Ahmad A.R.; Liam C.K.; de Marinis F.; Tassone P.; Molla A.I.; Calles Blanco A.; Lazaro Quintela M.E.; Felip Font E.; Dingemans A.-M.; Bui L. |
| 臺大學術典藏 |
2021-04-20T03:46:14Z |
Latent tuberculosis infection treatment for prison inmates: A randomised controlled trial
|
Chan P.-C.; Yang C.-H.; Chang L.-Y.; Wang K.-F.; Lu B.-Y.; Lu C.-Y.; Shao P.-L.; Hsueh P.-R.; CHI-TAI FANG; Huang L.-M. |
